Advertisement

Methodology: Dye and Isotope Method

  • Shinichi KinamiEmail author
  • Takeo Kosaka
Chapter

Abstract

Sentinel node (SN) biopsy has been attempted for digestive tract cancers, including esophageal, gastric, colon, and rectal cancers. Among these cancers, tailor-made surgical procedures guided by SN navigation have been planned for gastric cancer, while ultrastaging by SN biopsy is conducted for colon cancer. SN biopsy is a complex multistep surgical technique. This technique requires a suitable limitation of the indication, the selection of an adequate tracer, a proper tracer injection method, the objective detection of tracer uptake by the nodes, a reliable biopsy technique for the nodes that showed tracer uptake, and the precise detection of nodal metastasis. The selection of an adequate tracer for SN mapping has been an important issue. The advantages of dye methods are low cost, tractable, no radioactivity, and the direct visualization of the lymphatic canals and primary lymphatic drainage areas. The disadvantages of dye method are lack of objectivity, difficulty for digitizing, and quick washing out and deterioration. The advantages of radioactive imaging (RI) methods are high detection ability, objectivity, ease of digitizing, and possibility of easily distinguishing SN from secondary nodes. The disadvantages of the RI method are high cost, difficulty in handling, exposure to radioactivity, difficulty in detection of lymphatic vessels and lymphatic basin, and shine-through effect in the surgical field. Therefore, combination mapping of the dye method and the RI method is recommended because of its synergistic effect. Surgeons can detect both primary lymphatic canals visually and the SN objectively.

Keywords

Sentinel node Gastric cancer Combination mapping 

References

  1. 1.
    Morton DL, Wen DR, Wong JH, Economou JS, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–9.CrossRefGoogle Scholar
  2. 2.
    Kinami S, Oonishi T, Fujita J, Tomita Y, Funaki H, Fujita H, et al. Optimal settings and accuracy of indocyanine green fluorescence imaging for sentinel node biopsy in early gastric cancer. Oncol Lett. 2016;11:4055–62.CrossRefGoogle Scholar
  3. 3.
    Giuliano AE, Haigh PI, Brennan MB, Hansen NM, Kelley MC, Ye W, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol. 2000;18:2553–9.CrossRefGoogle Scholar
  4. 4.
    Takeuchi H, Saikawa Y, Oyama T, Kitagawa Y. Clinical application of sentinel node navigation surgery for esophageal cancer. Kyobu Geka. 2009;62:749–53.PubMedGoogle Scholar
  5. 5.
    Miwa K, Kinami S, Taniguchi K, Fushida S, Fujimura T, Nonomura A. Mapping sentinel nodes in patients with early-stage gastric carcinoma. Br J Surg. 2003;90:178–82.CrossRefGoogle Scholar
  6. 6.
    Saha S, Bilchik A, Wiese D, Espinosa M, Badin J, Ganatra BK, et al. Ultrastaging of colorectal cancer by sentinel lymph node mapping technique—a multicenter trial. Ann Surg Oncol. 2001;8:94S–8S.PubMedGoogle Scholar
  7. 7.
    Hladík P, Vizd’a J, Hadzi Nikolov D, Dvorák J, Voboril Z. Radio-guided sentinel node detection during the surgical treatment of rectal cancer. Nucl Med Commun. 2005;26:977–82.CrossRefGoogle Scholar
  8. 8.
    Matsuda T, Takeuchi H, Tsuwano S, Nakahara T, Mukai M, Kitagawa Y. Sentinel node mapping in adenocarcinoma of the esophagogastric junction. World J Surg. 2014;38:2337–44.CrossRefGoogle Scholar
  9. 9.
    Miwa K. Sentinel node concept and its application for cancer surgery. Nihon Geka Gakkai Zasshi. 2000;101:307–10.PubMedGoogle Scholar
  10. 10.
    Hiratsuka M, Miyashiro I, Ishikawa O, Furukawa H, Motomura K, Ohigashi H, et al. Application of sentinel node biopsy to gastric cancer surgery. Surgery. 2001;129:335–40.CrossRefGoogle Scholar
  11. 11.
    Carlini M, Carboni F, Petric M, Santoro R, Guadagni F, Marandino F, et al. Sentinel node in gastric cancer surgery. J Exp Clin Cancer Res. 2002;21:469–73.PubMedGoogle Scholar
  12. 12.
    Ichikura T, Morita D, Uchida T, Okura E, Majima T, Ogawa T, et al. Sentinel node concept in gastric carcinoma. World J Surg. 2002;26:318–22.CrossRefGoogle Scholar
  13. 13.
    Kitagawa Y, Fujii H, Mukai M, Kubota T, Otani Y, Kitajima M. Radio-guided sentinel node detection for gastric cancer. Br J Surg. 2002;89:604–8.CrossRefGoogle Scholar
  14. 14.
    Saha S, Sirop S, Korant A, Nalluri S, Machek OL, Desai D, et al. Detection of aberrant drainage after sentinel lymph node mapping and its impact on staging and change of operation in colon cancer. J Clin Oncol. 2011;29:500.CrossRefGoogle Scholar
  15. 15.
    Saha S, Sirop S, Korant A, Chakravarty B, Krishnaiah N, Wiese D, et al. The number of lymph node metastases as a prognostic indicator of disease-specific survival in the era of sentinel lymph node mapping in colon cancer. J Clin Oncol. 2009;20:27.Google Scholar
  16. 16.
    Kaburagi T, Takeuchi H, Oyama T, Nakamura R, Takahashi T, Wada N, et al. Radiotherapy, including sentinel lymph node, to superficial cancer of esophagus. J Clin Oncol. 2011;29:126.CrossRefGoogle Scholar
  17. 17.
    Dabbagh Kakhki VR, Bagheri R, Tehranian S, Shojaei P, Gholami H, et al. Accuracy of sentinel node biopsy in esophageal carcinoma: a systematic review and meta-analysis of the pertinent literature. Surg Today. 2014;44:607–19.CrossRefGoogle Scholar
  18. 18.
    Kawahara H, Watanabe K, Enomoto H, Tomoda M, Akiba T, Yanaga K. Sentinel node navigation surgery for lower rectal cancer. Anticancer Res. 2015;35:3489–93.PubMedGoogle Scholar
  19. 19.
    Eagon JC, Miedema BW, Kelly KA. Postgastrectomy syndromes. Surg Clin North Am. 1992;72:445–65.CrossRefGoogle Scholar
  20. 20.
    Kitagawa Y, Takeuchi H, Takagi Y, Natsugoe S, Terashima M, Murakami N, et al. Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan. J Clin Oncol. 2013;31:3704–10.CrossRefGoogle Scholar
  21. 21.
    Nakagawa T, Minamiya Y, Katayose Y, Saito H, Taguchi K, Imano H, et al. A novel method for sentinel lymph node mapping using magnetite in patients with non-small cell lung cancer. J Thorac Cardiovasc Surg. 2003;126:563–7.CrossRefGoogle Scholar
  22. 22.
    Ueno H, Hihara J, Shimizu K, Osaki A, Yamashita Y, Yoshida K, et al. Experimental study on fluorescent microspheres as a tracer for sentinel node detection. Anticancer Res. 2005;25:821–5.PubMedGoogle Scholar
  23. 23.
    Kim S, Lim YT, Soltesz EG, De Grand AM, Lee J, Nakayama A, et al. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol. 2004;22:93–7.CrossRefGoogle Scholar
  24. 24.
    Suga K, Ogasawara N, Okada M, Matsunaga N. Interstitial CT lymphography-guided localization of breast sentinel lymph node: preliminary results. Surgery. 2003;133:170–9.CrossRefGoogle Scholar
  25. 25.
    Wallace AM, Hoh CK, Vera DR, Darrah DD, Schulteis G. Lymphoseek: a molecular radiopharmaceutical for sentinel node detection. Ann Surg Oncol. 2003;10:531–8.CrossRefGoogle Scholar
  26. 26.
    Kinami S, Fujimura T, Ojima E, Fushida S, Ojima T, Funaki H, et al. PTD classification: proposal for a new classification of gastric cancer location based on physiological lymphatic flow. Int J Clin Oncol. 2008;13:320–9.CrossRefGoogle Scholar
  27. 27.
    Bedrosian I, Scheff AM, Mick R, Callans LS, Bucky LP, Spitz FR, et al. 99mTc-human serum albumin: an effective radiotracer for identifying sentinel lymph nodes in melanoma. J Nucl Med. 1999;40:1143–8.PubMedGoogle Scholar
  28. 28.
    Zulfikaroglu B, Koc M, Ozmen MM, Kucuk NO, Ozalp N, Aras G. Intraoperative lymphatic mapping and sentinel lymph node biopsy using radioactive tracer in gastric cancer. Surgery. 2005;138:899–904.CrossRefGoogle Scholar
  29. 29.
    Watanabe T, Kimijima I, Ohtake T, Tsuchiya A, Shishido F, Takenoshita S. Sentinel node biopsy with technetium-99m colloidal rhenium sulphide in patients with breast cancer. Br J Surg. 2001;88:704–7.CrossRefGoogle Scholar
  30. 30.
    Uenosono Y, Natsugoe S, Higashi H, Ehi K, Miyazono F, Ishigami S, et al. Evaluation of colloid size for sentinel nodes detection using radioisotope in early gastric cancer. Cancer Lett. 2003;200:19–24.CrossRefGoogle Scholar
  31. 31.
    Higashi H, Natsugoe S, Uenosono Y, Ehi K, Arigami T, Nakabeppu Y, et al. Particle size of tin and phytate colloid in sentinel node identification. J Surg Res. 2004;121:1–4.CrossRefGoogle Scholar
  32. 32.
    Hayashi H, Ochiai T, Mori M, Karube T, Suzuki T, Gunji Y, et al. Sentinel lymph node mapping for gastric cancer using a dual procedure with dye- and gamma probe-guided techniques. J Am Coll Surg. 2003;196:68–74.CrossRefGoogle Scholar
  33. 33.
    Wang Z, Dong ZY, Chen JQ, Liu JL. Diagnostic value of sentinel lymph node biopsy in gastric cancer: a meta-analysis. Ann Surg Oncol. 2012;19:1541–50.CrossRefGoogle Scholar
  34. 34.
    Clarke D, Newcombe RG, Mansel RE. The learning curve in sentinel node biopsy: the ALMANAC experience. Ann Surg Oncol. 2004;11:211S–5S.CrossRefGoogle Scholar
  35. 35.
    Miyashiro I, Hiratsuka M, Sasako M, Sano T, Mizusawa J, Nakamura K, et al. High false-negative proportion of intraoperative histological examination as a serious problem for clinical application of sentinel node biopsy for early gastric cancer: final results of the Japan Clinical Oncology Group multicenter trial JCOG0302. Gastric Cancer. 2014;17:316–23.CrossRefGoogle Scholar
  36. 36.
    Takeuchi H, Ueda M, Oyama T, Shimizu Y, Kitagawa Y. Molecular diagnosis and translymphatic chemotherapy targeting sentinel lymph nodes of patients with early gastrointestinal cancers. Digestion. 2010;82:187–91.CrossRefGoogle Scholar
  37. 37.
    Yaguchi Y, Sugasawa H, Tsujimoto H, Takata H, Nakabayashi K, Ichikura T, et al. One-step nucleic acid amplification (OSNA) for the application of sentinel node concept in gastric cancer. Ann Surg Oncol. 2011;18:2289–96.CrossRefGoogle Scholar
  38. 38.
    Kusano M, Tajima Y, Yamazaki K, Kato M, Watanabe M, Miwa M. Sentinel node mapping guided by indocyanine green fluorescence imaging: a new method for sentinel node navigation surgery in gastrointestinal cancer. Dig Surg. 2008;25:103–8.CrossRefGoogle Scholar
  39. 39.
    Miyashiro I, Miyoshi N, Hiratsuka M, Kishi K, Yamada T, Ohue M, et al. Detection of sentinel node in gastric cancer surgery by indocyanine green fluorescence imaging: comparison with infrared imaging. Ann Surg Oncol. 2008;15:1640–3.CrossRefGoogle Scholar
  40. 40.
    Yoshida M, Kubota K, Kuroda J, Ohta K, Nakamura T, Saito J, et al. Indocyanine green injection for detecting sentinel nodes using color fluorescence camera in the laparoscopy-assisted gastrectomy. J Gastroenterol Hepatol. 2012;27(Suppl 3):29–33.CrossRefGoogle Scholar
  41. 41.
    Tajima Y, Yamazaki K, Masuda Y, Kato M, Yasuda D, Aoki T, et al. Sentinel node mapping guided by indocyanine green fluorescence imaging in gastric cancer. Ann Surg. 2009;249:58–62.CrossRefGoogle Scholar
  42. 42.
    Brouwer OR, Buckle T, Vermeeren L, Klop WM, Balm AJ, van der Poel HG, et al. Comparing the hybrid fluorescent-radioactive tracer indocyanine green-99mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT/CT. J Nucl Med. 2012;53:1034–40.CrossRefGoogle Scholar
  43. 43.
    Frontado LM, Brouwer OR, van den Berg NS, Mathéron HM, Vidal-Sicart S, van Leeuwen FW, et al. Added value of the hybrid tracer indocyanine green-99mTc-nanocolloid for sentinel node biopsy in a series of patients with different lymphatic drainage patterns. Rev Esp Med Nucl Imagen Mol. 2013;32:227–33.PubMedGoogle Scholar
  44. 44.
    Heuveling DA, Visser GW, de Groot M, de Boer JF, Baclayon M, et al. Nanocolloidal albumin-IRDye 800CW: a near-infrared fluorescent tracer with optimal retention in the sentinel lymph node. Eur J Nucl Med Mol Imaging. 2012;39:1161–8.CrossRefGoogle Scholar
  45. 45.
    Kong SH, Noh YW, Suh YS, Park HS, Lee HJ, Kang KW, et al. Evaluation of the novel near-infrared fluorescence tracers pullulan polymer nanogel and indocyanine green/γ-glutamic acid complex for sentinel lymph node navigation surgery in large animal models. Gastric Cancer. 2015;18:55–64.CrossRefGoogle Scholar
  46. 46.
    Toyota T, Fujito H, Suganami A, Ouchi T, Ooishi A, Aoki A, et al. Near-infrared-fluorescence imaging of lymph nodes by using liposomally formulated indocyanine green derivatives. Bioorg Med Chem. 2014;22:721–7.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Department of Surgical OncologyKanazawa Medical UniversityIshikawaJapan

Personalised recommendations